Terms: = Skin cancer AND PTCH1, RP11-435O5_3, Q13635, PTCH, 5727, HPE7, FLJ26746, NBCCS, BCNS, PTC1, ENSG00000185920, FLJ42602 AND Treatment
104 results:
1. Laser-assisted topical delivery of vismodegib reduces hedgehog gene expression in human basal cell carcinomas in vivo.
Olesen UH; Pedersen KK; Togsverd-Bo K; Biskup E; Nielsen AL; Jackerott M; Clergeaud G; Andresen TL; Haedersdal M
Lasers Surg Med; 2024 Mar; 56(3):239-248. PubMed ID: 38311811
[TBL] [Abstract] [Full Text] [Related]
2. Dynamic optical coherence tomography evaluation in locally advanced basal cell carcinoma during sonidegib treatment.
Cantisani C; Musolff N; Longo C; Di Guardo A; Rovaldi E; Rossi G; Sasso F; Farnetani F; Rega F; Bánvölgyiv A; Azzella G; Paolino G; Pellacani G
J Eur Acad Dermatol Venereol; 2024 May; 38(5):967-973. PubMed ID: 38270330
[TBL] [Abstract] [Full Text] [Related]
3. Combined Carbon Dioxide Laser with Photodynamic Therapy for Nodular Basal Cell Carcinoma Monitored by Reflectance Confocal Microscopy.
Alma A; Pongetti L; Clementi A; Chester J; Toccaceli M; Ciardo S; Zappia E; Manfredini M; Pellacani G; Greco M; Bennardo L; Farnetani F
Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256291
[No Abstract] [Full Text] [Related]
4. [The molecular genetic aspects of basal cell carcinoma from the position of population health preservation].
Khabriev RU; Sadykova RN; Mingazova EN; Bespyatykh JA
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2023 Sep; 31(5):946-950. PubMed ID: 37898882
[TBL] [Abstract] [Full Text] [Related]
5. Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series.
Wescott R; Samlowski W
Curr Oncol; 2023 Oct; 30(10):9156-9167. PubMed ID: 37887561
[TBL] [Abstract] [Full Text] [Related]
6. [Basal cell nevus syndrome: the interface between dentistry and dermatology].
Cosgun B; Verkouteren BJA; Kessler PAWH; Mosterd K
Ned Tijdschr Tandheelkd; 2023 May; 130(5):227-231. PubMed ID: 37157987
[TBL] [Abstract] [Full Text] [Related]
7. Novel Approaches in Non-Melanoma skin cancers-A Focus on Hedgehog Pathway in Basal Cell Carcinoma (BCC).
Chmiel P; Kłosińska M; Forma A; Pelc Z; Gęca K; Skórzewska M
Cells; 2022 Oct; 11(20):. PubMed ID: 36291078
[TBL] [Abstract] [Full Text] [Related]
8. Impaired Wnt/beta-catenin and protein patched homolog 1 signaling in extraocular sebaceous carcinoma: A clinical and histopathological study.
Cheng AY; Lan J; Lee CH
J Dermatol; 2022 Jun; 49(6):600-606. PubMed ID: 35318716
[TBL] [Abstract] [Full Text] [Related]
9. Metastatic Basal Cell Carcinoma Arising From a Primary Cutaneous Carcinosarcoma.
Sterner J; Rizk K; Braudis K; Tuncer T; Smith E
Oncology (Williston Park); 2021 Dec; 35(12):812-815. PubMed ID: 35088998
[TBL] [Abstract] [Full Text] [Related]
10. GLI-1 polymorphisms of Hedgehog pathway as novel risk and prognostic biomarkers in melanoma patients.
Dunjic M; Lukic N; Djordjevic B; Uzelac B; Ostojic N; Supic G
Melanoma Res; 2022 Feb; 32(1):11-17. PubMed ID: 34939981
[TBL] [Abstract] [Full Text] [Related]
11. Novel ptch1 and concurrent TP53 mutations in four patients with numerous non-syndromic basal cell carcinomas: The paradigm of oncogenic synergy.
Dasgeb B; Pajouhanfar S; Jazayeri A; Schoenberg E; Kumar G; Fortina P; Berger AC; Uitto J
Exp Dermatol; 2022 May; 31(5):736-742. PubMed ID: 34862824
[TBL] [Abstract] [Full Text] [Related]
12. Dermabrasion combined with photodynamic therapy: a new option for the treatment of non-melanoma skin cancer.
Yu N; Luo X; Wei T; Zhang Q; Yu J; Wu L; Su J; Chen M; Huang K; Li F; Xie Y; Fang F; Zhang L; He R; Chen X; Zhao S; Bu W
Lasers Med Sci; 2022 Mar; 37(2):1255-1263. PubMed ID: 34365550
[TBL] [Abstract] [Full Text] [Related]
13. Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial.
Kahana A; Unsworth SP; Andrews CA; Chan MP; Bresler SC; Bichakjian CK; Durham AB; Demirci H; Elner VM; Nelson CC; Kim DS; Joseph SS; Swiecicki PL; Worden FP
Oncologist; 2021 Jul; 26(7):e1240-e1249. PubMed ID: 33988881
[TBL] [Abstract] [Full Text] [Related]
14. Methiothepin Increases Chemotherapy Efficacy against Resistant Melanoma Cells.
Durand N; Simsir M; Signetti L; Labbal F; Ballotti R; Mus-Veteau I
Molecules; 2021 Mar; 26(7):. PubMed ID: 33810240
[TBL] [Abstract] [Full Text] [Related]
15. MTOR promotes basal cell carcinoma growth through atypical PKC.
Chow RY; Levee TM; Kaur G; Cedeno DP; Doan LT; Atwood SX
Exp Dermatol; 2021 Mar; 30(3):358-366. PubMed ID: 33617094
[TBL] [Abstract] [Full Text] [Related]
16. Comparative histological and immunohistochemical changes in recurrent nodular basal cell carcinoma after photodynamic therapy.
Gracia-Cazaña T; Nicolás J; Cerro-Muñoz PA; González S; Juarranz Á; Gilaberte Y
Dermatol Ther; 2021 Mar; 34(2):e14779. PubMed ID: 33438310
[TBL] [Abstract] [Full Text] [Related]
17. The use of the photodynamic method in the treatment of recurrent basal cell carcinoma on the example of Gorlin-Goltz syndrome-management algorithm.
Osiecka BJ; Nockowski P; Szepietowski JC
Dermatol Ther; 2020 Nov; 33(6):e14499. PubMed ID: 33141489
[TBL] [Abstract] [Full Text] [Related]
18. Molecular Biology of Basal and Squamous Cell Carcinomas.
Boeckmann L; Martens MC; Emmert S
Adv Exp Med Biol; 2020; 1268():171-191. PubMed ID: 32918219
[TBL] [Abstract] [Full Text] [Related]
19. Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung cancer.
Gerber DE; Putnam WC; Fattah FJ; Kernstine KH; Brekken RA; Pedrosa I; Skelton R; Saltarski JM; Lenkinski RE; Leff RD; Ahn C; Padmanabhan C; Chembukar V; Kasiri S; Kallem RR; Subramaniyan I; Yuan Q; Do QN; Xi Y; Reznik SI; Pelosof L; Faubert B; DeBerardinis RJ; Kim J
Clin Cancer Res; 2020 Nov; 26(22):6017-6027. PubMed ID: 32847935
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of Patched-1 Protein Expression Level in Low Risk and High Risk Basal Cell Carcinoma Subtypes.
Almomani R; Khanfar M; Bodoor K; Al-Qarqaz F; Alqudah M; Hammouri H; Abu-Salah A; Haddad Y; Al Gargaz W; Mohaidat Z
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2851-2857. PubMed ID: 31554387
[TBL] [Abstract] [Full Text] [Related]
[Next]
